Cleared Traditional

K180233 - Eviva Stereotactic Guided Breast Biopsy System (FDA 510(k) Clearance)

Apr 2018
Decision
71d
Days
Class 2
Risk

K180233 is an FDA 510(k) clearance for the Eviva Stereotactic Guided Breast Biopsy System. This device is classified as a Instrument, Biopsy (Class II - Special Controls, product code KNW).

Submitted by Hologic, Inc. (Malborough, US). The FDA issued a Cleared decision on April 10, 2018, 71 days after receiving the submission on January 29, 2018.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1075.

Submission Details

510(k) Number K180233 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2018
Decision Date April 10, 2018
Days to Decision 71 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KNW — Instrument, Biopsy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1075

Similar Devices — KNW Instrument, Biopsy

All 10
ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit)
K252795 · Argon Medical Devices, Inc. · Feb 2026
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
K252681 · Bard Peripheral Vascular, Inc. · Dec 2025
Marquee™ Disposable Core Biopsy Instrument and Instrument Kit
K250032 · Bard Peripheral Vascular, Inc. · Jul 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K243945 · SurGenTec, LLC · Apr 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K240664 · SurGenTec, LLC · Aug 2024
EnCor Enspire™Breast Biopsy System (E4115, E4230)
K233220 · Senorx, Inc. · Oct 2023